Transplant Biomedicals is a Barcelona-based company that develops an innovative medical device to store and transport organs, focusing on livers and kidneys. The company was founded by Dr Carmen Peralta and Ignasi Heras as a spin-off of IDIBAPS-Hospital Clinic and is located in the Barcelona Activa Parc Tecnològic Barcelona Nord. Its core product aims to improve the quality and viability of kidney and liver transplants through better preservation and transport. The company plans to begin clinical trials and move the device into the clinical phase. It intends to use recent funding to cover technological development and to obtain CE marking to begin sales in Europe in 2018. To date the company has raised €3.5M in venture capital. Transplant Biomedicals develops an organ transport medical device designed to preserve organs during transport from donor hospitals to transplant centers. The device aims to improve preservation, enable use of marginal organs that are currently discarded, and help reduce transplant waiting lists. The company will use recently raised funds to continue to develop and commercialize its first product. Founded in 2014 as a spinoff from IDIBAPS and based in Barcelona, Spain, Transplant Biomedicals is led by Ignasi Heras, CEO and cofounder. It raised €1.5m in venture capital funding in the reported round.

Total raised

$4M

Funding rounds

2

Latest round

Equity

Latest activity

Jan 2017